Home › Compare › QTXB vs FCPT

QTXB vs FCPT: Dividend Comparison 2026

QTXB yields 400000.00% · FCPT yields 6.05%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 QTXB wins by $5.011119029548644e+32M in total portfolio value
10 years
QTXB
QTXB
● Live price
400000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5.011119029548644e+32M
Annual income
$500,865,583,351,836,840,000,000,000,000,000,000,000.00
Full QTXB calculator →
FCPT
FCPT
● Live price
6.05%
Share price
$23.65
Annual div
$1.43
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.1K
Annual income
$5,775.28
Full FCPT calculator →

Portfolio growth — QTXB vs FCPT

📍 QTXB pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodQTXBFCPT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, QTXB + FCPT cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
QTXB pays
FCPT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

QTXB
Annual income on $10K today (after 15% tax)
$34,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$425,735,745,849,061,300,000,000,000,000,000,000,000.00/yr
FCPT
Annual income on $10K today (after 15% tax)
$514.49/yr
After 10yr DRIP, annual income (after tax)
$4,908.99/yr
At 15% tax rate, QTXB beats the other by $425,735,745,849,061,300,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of QTXB + FCPT for your $10,000?

QTXB: 50%FCPT: 50%
100% FCPT50/50100% QTXB
Portfolio after 10yr
$2.505559514774322e+32M
Annual income
$250,432,791,675,918,420,000,000,000,000,000,000,000.00/yr
Blended yield
99.95%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on FCPT right now

QTXB
No analyst data
Altman Z
-14333.8
Piotroski
1/9
FCPT
Analyst Ratings
5
Buy
10
Hold
Consensus: Hold
Price Target
$27.00
+14.2% upside vs current
Range: $25.00 — $29.00
Altman Z
1.4
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

QTXB buys
0
FCPT buys
0
No recent congressional trades found for QTXB or FCPT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricQTXBFCPT
Forward yield400000.00% ✓6.05%
Annual dividend / share$2.00 ✓$1.43
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8% ✓
Portfolio after 10y$5.011119029548644e+32M$49.1K ✓
Annual income after 10y$500,865,583,351,836,840,000,000,000,000,000,000,000.00 ✓$5,775.28
Total dividends collected$5.010957816668433e+32M$24.1K ✓
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: QTXB vs FCPT ($10,000, DRIP)

YearQTXB PortfolioQTXB Income/yrFCPT PortfolioFCPT Income/yrGap
1← crossover$40,010,700$40,000,000.00$11,401$700.92+$40.00M → QTXB
2$149,615,521,729$149,572,710,280.37$13,064$864.84+$149615.51M → QTXB
3$522,880,052,725,200$522,719,964,116,949.25$15,051$1,072.48+$522880052.71M → QTXB
4$1,707,862,989,289,045,000$1,707,303,507,632,628,700.00$17,442$1,337.22+$1707862989289.03M → QTXB
5$5,213,509,402,845,684,000,000$5,211,681,989,447,144,000,000.00$20,340$1,677.08+$5213509402845684.00M → QTXB
6$14,874,219,058,409,543,000,000,000$14,868,640,603,348,497,000,000,000.00$23,880$2,116.57+$14874219058409543680.00M → QTXB
7$39,661,196,234,050,755,000,000,000,000$39,645,280,819,658,260,000,000,000,000.00$28,241$2,689.36+$3.966119623405075e+22M → QTXB
8$98,838,436,350,327,300,000,000,000,000,000$98,795,998,870,356,880,000,000,000,000,000.00$33,660$3,442.07+$9.88384363503273e+25M → QTXB
9$230,205,236,474,344,900,000,000,000,000,000,000$230,099,479,347,450,050,000,000,000,000,000,000.00$40,456$4,439.95+$2.302052364743449e+29M → QTXB
10$501,111,902,954,864,400,000,000,000,000,000,000,000$500,865,583,351,836,840,000,000,000,000,000,000,000.00$49,063$5,775.28+$5.011119029548644e+32M → QTXB

QTXB vs FCPT: Complete Analysis 2026

QTXB — Stock

QuantRx Biomedical Corporation engages in the development and commercialization of patented miniform pads (PADs) and PAD based over-the-counter products in the United States. It is also developing genomic diagnostics for the laboratory market based on its lateral flow patents, including RapidSense technology, a one-step lateral flow test. The company's PAD products are used for the treatment of hemorrhoids, minor vaginal infection, urinary incontinence, general catamenial uses, and other medical needs. Its products include InSync, a feminine hygienic interlabial pad; Unique miniform, a treated pad for the temporary relief of the itch and discomfort associated with hemorrhoids and minor vaginal infection, as well as an untreated pad for the daily protection of light urinary, vaginal, or anal leakage; and other treated miniform products. QuantRx Biomedical Corporation was incorporated in 1986 and is based in Tualatin, Oregon.

Full QTXB Calculator →

FCPT — REIT

FCPT, headquartered in Mill Valley, CA, is a real estate investment trust primarily engaged in the acquisition and leasing of restaurant properties. The Company seeks to grow its portfolio by acquiring additional real estate to lease, on a net basis, for use in the restaurant and retail industries.

Full FCPT Calculator →
📬

Get this QTXB vs FCPT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

QTXB vs SCHDQTXB vs JEPIQTXB vs OQTXB vs KOQTXB vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.